Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingfeng He

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
FEBS Letters|May 19, 2009
An anticoagulant peptide from the human hookworm, Ancylostoma duodenale that inhibits coagulation factors Xa and XIaWeiqiong Gan, Li Deng, Chen Yang, et al.
Scientific Reports|July 10, 2025
Evaluation of landslide susceptibility of mountain highway based on RF and SVM modelsQingfeng He, Shoulong Wu, Xia Zhao, et al.
Drug Design, Development and Therapy|October 21, 2024
Prediction of Pharmacokinetic Drug-Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic ModelingFengjiao Bu, Yong-Soon Cho, Qingfeng He, et al.
Drug Design, Development and Therapy|May 18, 2026
Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug-Drug Interactions of Flumatinib as Both a Victim and a PerpetratorMuyesaier Alifu, Xue Chu, Xinyan Zhu, et al.
Advanced Drug Delivery Reviews|September 14, 2024
Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectivesWen Yao Mak, Qingfeng He, Wenyu Yang, et al.
Pediatric Diabetes|August 18, 2025
Physiologically-Based Pharmacokinetics and Empirical Pharmacodynamic Modeling for Pediatric Henagliflozin Dosing: Clinical Insights for Chinese PatientsXinyue Zhang, Hao Xue, Jialei Xu, et al.
Frontiers in Pharmacology|June 11, 2026
Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactionsBowen Chen, Longjie Li, Wenhang Xu, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Investigation of the <i>ABCB1</i> Gene Polymorphism and Food Effects on the Avatrombopag Pharmacokinetics in Chinese Individuals: A Population Pharmacokinetic/Pharmacodynamic AnalysisXin Liu, Lulu Chen, Gehang Ju, et al.
Journal of Pharmaceutical Sciences|June 8, 2025
Physiologically-based pharmacokinetic modeling of rosuvastatin in Chinese: Predicting the impact of SLCO1B1 and ABCG2 genetic variants and hepatic impairment on drug exposureLongjie Li, Xinyan Zhu, Wenhang Xu, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2025
Population pharmacokinetics and thrombocytopenia risk assessment of linezolid in liver transplant recipientsXiaoping Shi, Wenyu Yang, Fanyu Zhao, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
FEBS Letters|May 19, 2009
An anticoagulant peptide from the human hookworm, Ancylostoma duodenale that inhibits coagulation factors Xa and XIaWeiqiong Gan, Li Deng, Chen Yang, et al.
Scientific Reports|July 10, 2025
Evaluation of landslide susceptibility of mountain highway based on RF and SVM modelsQingfeng He, Shoulong Wu, Xia Zhao, et al.
Drug Design, Development and Therapy|October 21, 2024
Prediction of Pharmacokinetic Drug-Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic ModelingFengjiao Bu, Yong-Soon Cho, Qingfeng He, et al.
Drug Design, Development and Therapy|May 18, 2026
Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug-Drug Interactions of Flumatinib as Both a Victim and a PerpetratorMuyesaier Alifu, Xue Chu, Xinyan Zhu, et al.
Advanced Drug Delivery Reviews|September 14, 2024
Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectivesWen Yao Mak, Qingfeng He, Wenyu Yang, et al.
Pediatric Diabetes|August 18, 2025
Physiologically-Based Pharmacokinetics and Empirical Pharmacodynamic Modeling for Pediatric Henagliflozin Dosing: Clinical Insights for Chinese PatientsXinyue Zhang, Hao Xue, Jialei Xu, et al.
Frontiers in Pharmacology|June 11, 2026
Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactionsBowen Chen, Longjie Li, Wenhang Xu, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Investigation of the <i>ABCB1</i> Gene Polymorphism and Food Effects on the Avatrombopag Pharmacokinetics in Chinese Individuals: A Population Pharmacokinetic/Pharmacodynamic AnalysisXin Liu, Lulu Chen, Gehang Ju, et al.
Journal of Pharmaceutical Sciences|June 8, 2025
Physiologically-based pharmacokinetic modeling of rosuvastatin in Chinese: Predicting the impact of SLCO1B1 and ABCG2 genetic variants and hepatic impairment on drug exposureLongjie Li, Xinyan Zhu, Wenhang Xu, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2025
Population pharmacokinetics and thrombocytopenia risk assessment of linezolid in liver transplant recipientsXiaoping Shi, Wenyu Yang, Fanyu Zhao, et al.
Pageof 7